Impella versus VA-ECMO for the treatment of patients with cardiogenic shock: the Impella Network Project - observational study protocol for cost-effectiveness and budget impact analyses.
Vittoria ArditoCarla RognoniMarina PieriAlessandro BarboneCarlo BriguoriEmanuele CigalaGino GerosaMario IannacconeAntonio LoforteMarco MariniAndrea MontaltoJacopo OregliaDavide PaciniMauro PennacchiVincenzo PestrichellaItalo PortoPierluigi StefanoGiuseppe TarantiniSerafina ValentePietro VandoniRosanna TarriconeAnna Mara ScandroglioPublished in: BMJ open (2024)
As of May 2024, most of the clinical centres submitted the documentation to their ethical committee (N=13; 76%), six centres received ethical approval and two centres started to enrol patients. Study results will be published in peer-reviewed publications and disseminated through conference presentations.
Keyphrases
- newly diagnosed
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- quality improvement
- chronic kidney disease
- end stage renal disease
- randomized controlled trial
- cross sectional
- left ventricular assist device
- intensive care unit
- ejection fraction
- prognostic factors
- patient reported outcomes